Expert perspectives on the use of saw palmetto extracts to manage patients with benign prostatic hyperplasia and lower urinary tract symptoms.
EP. 1: An Overview of Treatment Approaches to BPH and LUTS
Expert perspective on the treatment landscape of benign prostatic hyperplasia and lower urinary tract symptoms.
EP. 2: Saw Palmetto Extract in BPH and LUTS: Mechanism of Action and Efficacy
Bilal Chughtai, MD, shares insight on the use of saw palmetto extracts in benign prostatic hyperplasia and lower urinary tract symptoms.
EP. 3: Regulation of Nutraceuticals/Food Supplements in BPH and LUTS
A brief overview of regulation in nutraceuticals/food supplement use for patients with benign prostatic hyperplasia and lower urinary tract symptoms.
EP. 4: BPH and LUTS: Interpreting Clinical Data on Saw Palmetto Extracts
Expert insight on clinical trial data informing the use of saw palmetto extracts in benign prostatic hyperplasia and lower urinary tract symptoms.
EP. 5: Adverse Event Profile of Saw Palmetto Extracts in BPH and LUTS
A brief review of the safety profile associated with use of saw palmetto extracts in benign prostatic hyperplasia and lower urinary tract symptoms.
EP. 6: Saw Palmetto Extracts in BPH and LUTS: Practical Advice on Patient Education
Closing out his discussion on saw palmetto extracts in benign prostatic hyperplasia and lower urinary tract symptoms, Bilal Chughtai, MD, shares practical advice for physicians.
Expert discusses the promise of emerging MISTs for BPH
Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
FDA Advisory Committee unanimously votes against talazoparib plus enzalutamide for mCRPC
FDA Advisory Committee finds evidence for UGN-102 inconclusive, cites uncertainty in benefit-risk